Sr. Director, Specialty Respiratory Strategic Engagement & Portfolio and Pipeline Strategy

Sr. Director, Specialty Respiratory Strategic Engagement & Portfolio and Pipeline Strategy

Location:
Field Based

The Sr. Director, Specialty Respiratory Strategic Engagement & Portfolio/Pipeline Strategy leads the integrated U.S. commercial strategy for the Specialty Respiratory portfolio and pipeline within Marketing, serving as the primary commercial voice for Specialty Respiratory across the asset continuum from early development through lifecycle management. This role owns the strategic framework for external expert engagement, speaker programs, and congresses, and ensures commercially grounded insight generation and input into development decisions in close partnership with cross-functional teams.

This role leads a multi-layered organization, including:

• Director, Specialty Respiratory Strategic Engagement (and associated Strategic Engagement Marketing Managers + TLL team)
• Director, Specialty Respiratory Portfolio and Pipeline Strategy

The Sr. Director ensures that:

• U.S. customer insights (HCP, payer, patient) are systematically generated and embedded into pipeline development, portfolio decisions, and brand strategy
• Strategic engagement capabilities (TLLs, congress, P2P, external experts) are fully aligned to and accelerate portfolio and pipeline priorities
• The organization operates as a single, insight-driven, customer-centric engine from Phase 2 through lifecycle management and launch

This role serves as the single point of accountability for U.S. strategic integration across development and commercialization for Specialty Respiratory.

• Define and lead the integrated U.S. strategy across portfolio, pipeline, and strategic engagement for Specialty Respiratory medicines.
• Ensure tight linkage between early asset strategy and in-market execution, connecting development decisions with customer engagement and insights.
• Serve as the voice of the U.S. commercial for Specialty Respiratory across governance forums and enterprise decision-making bodies.
• Drive alignment across Brand, Medical, Market Access, R&D, and Commercial leadership where appropriate and applicable.
• Operates as the Marketing VP’s primary strategic deputy for Specialty Respiratory, holding functional decision-making authority over U.S. engagement investment priorities, external expert strategy, and the commercial input into pipeline decisions. Accountable for ensuring recommendations reaching VP and above are fully developed, compliant with all US Policies and SOPs, cross-functionally aligned, and commercially defensible.

• Oversee development of integrated U.S. portfolio strategies across in-line and pipeline Specialty Respiratory assets (Phase 2 through launch), ensuring alignment with brand strategy, commercial objectives, and medical priorities.
• Ensure delivery of robust U.S. market analyses, insights, and assumptions that inform stage-gate decisions, financial valuations, and investment prioritization.
• Lead lifecycle strategy, including indication prioritization, sequencing, and lifecycle extension opportunities, informed by insights from in-line brands, customer experience, and external experts.
• Embed payer, access, and value considerations early in development planning in partnership with Market Access, Health Outcomes, and Medical Affairs.

• Set the Specialty Respiratory strategy for HCP and external expert engagement, ensuring alignment with portfolio and pipeline priorities.
• Ensure external expert insights are systematically captured, synthesized, and translated into action for brand, portfolio, and pipeline decisions.
• Drive a consistent, high-impact, and compliant external engagement model aligned to strategic priorities.

• Establish a closed-loop insight engine connecting TLL field insights, market research, analytics, and competitive intelligence.
• Ensure insights are translated into clear, actionable recommendations for senior leadership and cross-functional partners.
• Champion a test-and-learn culture to continuously optimize engagement models,…